table of content
1 Study Coverage
1.1 Non-Invasive Cancer Diagnostics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Non-Invasive Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Non-Invasive Cancer Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Non-Invasive Cancer Diagnostics Market Size for the Year 2017-2028
1.3 Non-Invasive Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Non-Invasive Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Non-Invasive Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Non-Invasive Cancer Diagnostics Market Dynamics
1.4.1 Non-Invasive Cancer Diagnostics Industry Trends
1.4.2 Non-Invasive Cancer Diagnostics Market Drivers
1.4.3 Non-Invasive Cancer Diagnostics Market Challenges
1.4.4 Non-Invasive Cancer Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Non-Invasive Cancer Diagnostics by Type
2.1 Non-Invasive Cancer Diagnostics Market Segment by Type
2.1.1 CTCs
2.1.2 CTNAS
2.1.3 Exosomes
2.2 Global Non-Invasive Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Non-Invasive Cancer Diagnostics Market Size by Type (2017-2028)
2.4 United States Non-Invasive Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Non-Invasive Cancer Diagnostics Market Size by Type (2017-2028)
3 Non-Invasive Cancer Diagnostics by Application
3.1 Non-Invasive Cancer Diagnostics Market Segment by Application
3.1.1 Blood
3.1.2 Urine
3.1.3 Saliva
3.2 Global Non-Invasive Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Non-Invasive Cancer Diagnostics Market Size by Application (2017-2028)
3.4 United States Non-Invasive Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Non-Invasive Cancer Diagnostics Market Size by Application (2017-2028)
4 Global Non-Invasive Cancer Diagnostics Competitor Landscape by Company
4.1 Global Non-Invasive Cancer Diagnostics Market Size by Company
4.1.1 Top Global Non-Invasive Cancer Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Non-Invasive Cancer Diagnostics Revenue by Player (2017-2022)
4.2 Global Non-Invasive Cancer Diagnostics Concentration Ratio (CR)
4.2.1 Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Non-Invasive Cancer Diagnostics in 2021
4.2.3 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Non-Invasive Cancer Diagnostics Headquarters, Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Non-Invasive Cancer Diagnostics Headquarters and Area Served
4.3.2 Global Non-Invasive Cancer Diagnostics Companies Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Non-Invasive Cancer Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Non-Invasive Cancer Diagnostics Market Size by Company
4.5.1 Top Non-Invasive Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Non-Invasive Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Non-Invasive Cancer Diagnostics Market Size by Region
5.1 Global Non-Invasive Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Non-Invasive Cancer Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Non-Invasive Cancer Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Non-Invasive Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Gen-Probe Inc
7.1.1 Gen-Probe Inc Company Details
7.1.2 Gen-Probe Inc Business Overview
7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
7.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.1.5 Gen-Probe Inc Recent Development
7.2 Digene Corporation
7.2.1 Digene Corporation Company Details
7.2.2 Digene Corporation Business Overview
7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
7.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.2.5 Digene Corporation Recent Development
7.3 Quest Diagnostics Inc
7.3.1 Quest Diagnostics Inc Company Details
7.3.2 Quest Diagnostics Inc Business Overview
7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
7.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.3.5 Quest Diagnostics Inc Recent Development
7.4 Cancer, Genetics Inc
7.4.1 Cancer, Genetics Inc Company Details
7.4.2 Cancer, Genetics Inc Business Overview
7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
7.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.4.5 Cancer, Genetics Inc Recent Development
7.5 BIOVIEW Inc
7.5.1 BIOVIEW Inc Company Details
7.5.2 BIOVIEW Inc Business Overview
7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
7.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.5.5 BIOVIEW Inc Recent Development
7.6 AVIVA Biosciences Corporation
7.6.1 AVIVA Biosciences Corporation Company Details
7.6.2 AVIVA Biosciences Corporation Business Overview
7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
7.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.6.5 AVIVA Biosciences Corporation Recent Development
7.7 Laboratory Corporation of America Holdings (LabCorp)
7.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
7.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
7.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
7.8 A&G Pharmaceutical
7.8.1 A&G Pharmaceutical Company Details
7.8.2 A&G Pharmaceutical Business Overview
7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
7.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.8.5 A&G Pharmaceutical Recent Development
7.9 Affymetrix Inc
7.9.1 Affymetrix Inc Company Details
7.9.2 Affymetrix Inc Business Overview
7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
7.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.9.5 Affymetrix Inc Recent Development
7.10 Precision Therapeutics
7.10.1 Precision Therapeutics Company Details
7.10.2 Precision Therapeutics Business Overview
7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
7.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.10.5 Precision Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
